title: [The adult respiratory distress syndrome as a complication of the APSAC treatment of acute myocardial infarct. Apropos a case].
abstract: Thrombolytic therapy has shown to be effective in acute myocardial infarction, and its benefits on left ventricular function and later survival are well known. However it is not a therapy free of complications and side effects. Allergic reactions, anafilaxia, hypotension, and several kinds of hemorrhages have been reported. Adult respiratory distress syndrome after streptokinase administration has been also described, and one case, recently communicated, after APSAC therapy. We present the case of a male with acute myocardial infarction who developed adult respiratory distress syndrome after APSAC therapy, with different outcome than the first case published in the literature. Finally, we discussed the mechanisms by means these drugs can produce such a complication.
authors.affiliation: Servicio de Cardiología, Hospital Universitario de Canarias, Tenerife.
authors.forename: M J
authors.initials: MJ
authors.lastname: García González
authors.forename: F
authors.initials: F
authors.lastname: Bosa Ojeda
authors.forename: A
authors.initials: A
authors.lastname: Barragán Acea
authors.forename: F
authors.initials: F
authors.lastname: Marrero Rodríguez
authors.forename: I
authors.initials: I
authors.lastname: Laynez Cerdeña
authors.forename: A
authors.initials: A
authors.lastname: Lara Padrón
authors.forename: J
authors.initials: J
authors.lastname: Lacalzada Almeida
authors.forename: D
authors.initials: D
authors.lastname: de Armas Trujillo
mesh_terms: D000328:Adult; D016255:Anistreplase / Q000009:adverse effects*; D006801:Humans; D008297:Male; D009203:Myocardial Infarction / Q000150:complications* / Q000188:drug therapy; D012128:Respiratory Distress Syndrome / Q000139:chemically induced* / Q000175:diagnosis; D015912:Thrombolytic Therapy / Q000009:adverse effects*; D013997:Time Factors
chemical_list: D016255:Anistreplase
vernacular_title: Síndrome de distrés respiratorio del adulto como complicación del tratamiento del infarto agudo de miocardio con APSAC. A propósito de un caso.